Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Ordinary Shares, par value $0.0001 per share
-
Shares outstanding
-
172M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
9.79K
-
Shares change
-
-76.7K
-
Total reported value, excl. options
-
$399K
-
Value change
-
-$3.13M
-
Number of buys
-
1
-
Number of sells
-
-1
-
Price
-
$40.76
Significant Holders of Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR) as of Q4 2023
2 filings reported holding GPCR - Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share as of Q4 2023.
Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.79K shares
of 172M outstanding shares and own 0.01% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (4.37M shares), FMR LLC (4.03M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (2.6M shares), Avoro Capital Advisors LLC (2.33M shares), FEDERATED HERMES, INC. (2.27M shares), TCG Crossover Management, LLC (2.11M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.76M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.68M shares), JANUS HENDERSON GROUP PLC (1.54M shares), and T. Rowe Price Investment Management, Inc. (1.31M shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.